Tetrahydroharmine
| Clinical data | |
|---|---|
| Other names | THH; 1,2,3,4-Tetrahydroharmine; Leptaflorine; 7-Methoxy-1,2,3,4-tetrahydroharman; 7-Methoxy-1-methyl-1,2,3,4-tetrahydro-β-carboline; 7-MeO-THH |
| Routes of administration | Oral |
| Drug class | Hallucinogen; Oneirogen |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Elimination half-life | 4.7–8.8 hours |
| Duration of action | Unknown |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H16N2O |
| Molar mass | 216.284 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Tetrahydroharmine (THH), also known as 7-methoxy-1,2,3,4-tetrahydroharman (7-MeO-THH), is a fluorescent indole alkaloid and β-carboline that occurs in the tropical liana species Banisteriopsis caapi. It is an oneirogenic hallucinogen similarly to harmaline. Conversely however, in contrast to other harmala alkaloids, it is very weak as a monoamine oxidase inhibitor (MAOI).
Category:
- Drugs not assigned an ATC code